Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Body iron, serum ferritin, and nonalcoholic fatty liver disease.

Shim JJ.

Korean J Hepatol. 2012 Mar;18(1):105-7. doi: 10.3350/kjhep.2012.18.1.105. No abstract available.

2.

[Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease].

Moon JH, Park SH, Oh KC, Jung JO, Shin WG, Kim JP, Kim KO, Park CH, Hahn T, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK, Jun SY.

Korean J Gastroenterol. 2006 Jun;47(6):432-9. Korean.

3.

Binding of serum ferritin to concanavalin A in patients with iron overload and with chronic liver disease.

Chapman RW, Gorman A, Laulicht M, Hussain MA, Sherlock S, Hoffbrand AV.

J Clin Pathol. 1982 May;35(5):481-6.

4.

Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease.

Valberg LS, Ghent CN, Lloyd DA, Frei JV, Chamberlain MJ.

Can Med Assoc J. 1978 Aug 12;119(3):229-36.

5.

Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.

Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G.

Am J Clin Nutr. 2008 May;87(5):1374-83.

6.

Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S.

Am J Gastroenterol. 2007 Jun;102(6):1251-8.

PMID:
17391316
7.

Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance.

Nielsen P, Günther U, Dürken M, Fischer R, Düllmann J.

J Lab Clin Med. 2000 May;135(5):413-8.

PMID:
10811057
8.

[Relationship of serum iron and ferritin with the indicators for hepatic fibrosis].

Huang CW, Bai L, Cai JJ, Guo W, Lan L.

Di Yi Jun Yi Da Xue Xue Bao. 2003 May;23(5):466-8. Chinese.

PMID:
12754132
9.

Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Uraz S, Aygun C, Sonsuz A, Ozbay G.

Dig Dis Sci. 2005 May;50(5):964-9.

PMID:
15906776
10.

[Clinical value of hepatic fibrosis parameters and serum ferritin in obese children with nonalcoholic fatty liver disease].

Shi HB, Fu JF, Wang CL.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008 May;37(3):245-9. Chinese.

PMID:
18546525
11.

Importance of iron and iron metabolism in nonalcoholic fatty liver disease.

Baptista-Gonzalez H, Chavez-Tapia NC, Zamora-Valdés D, Uribe M, Mendez-Sanchez N.

Mini Rev Med Chem. 2008 Feb;8(2):171-4. Review.

PMID:
18289100
12.

Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.

Van Der Weyden MB, Fong H, Salem HH, Batey RG, Dudley FJ.

Br Med J (Clin Res Ed). 1983 Mar 5;286(6367):752-4.

13.

On the iron content of human serum ferritin, especially in acute viral hepaptitis and iron overload.

Zuyderhoudt FM, Linthorst C, Hengeveld P.

Clin Chim Acta. 1978 Nov 15;90(1):93-9.

PMID:
719893
14.

Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation.

Yoneda M, Nozaki Y, Endo H, Mawatari H, Iida H, Fujita K, Yoneda K, Takahashi H, Kirikoshi H, Inamori M, Kobayashi N, Kubota K, Saito S, Maeyama S, Hotta K, Nakajima A.

Dig Dis Sci. 2010 Mar;55(3):808-14. doi: 10.1007/s10620-009-0771-y.

PMID:
19267193
15.

Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases.

Sumida Y, Nakashima T, Yoh T, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Okanoue T, Nakamura H, Yodoi J.

Liver. 2001 Oct;21(5):295-9.

PMID:
11589765
16.

Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis.

Nielsen P, Engelhardt R, Düllmann J, Fischer R.

Blood Cells Mol Dis. 2002 Nov-Dec;29(3):451-8.

PMID:
12547235
17.

Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.

Lecube A, Hernández C, Simó R.

Diabetes Metab Res Rev. 2009 Jul;25(5):403-10. doi: 10.1002/dmrr.972. Review.

PMID:
19444865
18.

Use of the ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage.

Triadou P, Regnat-Lusinchi A, Girot R.

Eur J Haematol. 1989 Nov;43(5):423-7.

PMID:
2612615
19.

The risk factors of fibrosis in nonalcoholic steatohepatitis.

Fierbinţeanu-Braticevici C, Bengus A, Neamţu M, Usvat R.

Rom J Intern Med. 2002;40(1-4):81-8.

PMID:
15526543
20.
Items per page

Supplemental Content

Support Center